Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > RNA Diagnostic Test from Paraffin… >
RNA Diagnostic Test from Paraffin Improves Lung Cancer Diagnosis over Routine Microscopic Evaluation

Published: July 16, 2013.
By University of North Carolina Health Care
http://www.med.unc.edu

CHAPEL HILL, N.C. -- Knowing what type of lung cancer a patient has is critical to determine which drug will work best and which therapies are safest in the era of personalized medicine. Key to making that judgment is an adequate tumor specimen for the pathologist to determine the tumor's histology, a molecular description of a tumor based on the appearance of cells under a microscope. But not all specimens are perfect, and are sometimes so complex that a definitive diagnosis presents a challenge.

Scientists at the Universities of North Carolina and Utah have developed a histology expression predictor for the most common types of lung cancer: adenocarcinoma, carcinoid, small cell carcinoma and squamous cell carcinoma. This predictor can confirm histologic diagnosis in routinely collected paraffin samples of patients' tumors and can complement and corroborate pathologists' findings.

Their findings were reported in the July 2013 issue of the Journal of Molecular Diagnostics.

Neil Hayes, MD, MPH, associate professor of medicine and corresponding author of the study says, "As we learn more about the genetics of lung cancer, we can use that understanding to tailor therapies to the individual's tumor. Gene expression profiling has great potential for improving the accuracy of the histologic diagnosis. Historically, gene expression analysis has required fresh tumor tissue that is usually not possible in routine clinical care. We desperately needed to extend the analysis of genes (aka RNA) to paraffin samples that are routinely generated in clinical care, rather than fresh frozen tissue. That is the major accomplishment of the current study and one of the first large scale endeavors in lung cancer to show this is possible.

"Our predictor identifies the major histologic types of lung cancer in paraffin-embedded tissue specimens which is immediately useful in confirming the histologic diagnosis in difficult tissue biopsy specimens." Dr. Hayes is a member of UNC Lineberger Comprehensive Cancer Center.

The scientists used 442 samples of formalin-fixed paraffin-embedded specimens from lung cancer patients at UNC and the University of Utah Health Sciences Center as they developed their predictor.

First author Matthew Wilkerson, PhD, explains, "Our question was, 'Can histology be predicted accurately by gene expression?' We had lung cancer genes we already knew were differentially expressed in the different tumor types, so we measured them in tumor paraffin specimens. Next we developed a predictor in an independent set of tumor samples. We then compared the predictor to the actual clinical diagnosis and had additional pathologists review the samples. We showed accuracy as least as good as the pathologist. Our predictor exhibited a mean accuracy of 84 percent, and when compared with pathologist diagnoses, yielded similar accuracy and precision as the pathologists."

Dr. Hayes summarizes, "Going beyond meeting a current need of increasing the accuracy of histologic diagnosis is expected to be the ultimate benefit of this technology. There are many additional characteristics of tumors that could be leveraged for clinical purposes once the world of gene expression analysis from paraffin is efficient from clinical samples. We anticipate additional uses such as predicting responses to additional therapies and prognostication as near term additions."




Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


 
All comments are reviewed before being posted. We cannot accept messages that refer a product, or web site.If you are looking for a response to a question please use our another feedback page.
Related »

Cancer 
9/27/13 
Oncogenic Signatures Mapped in TCGA a Guide for the Development of Personalized Therapy
By Memorial Sloan-Kettering Cancer Center
New York, September 27, 2013 -- Clinical trial design for new cancer therapies has historically been focused on the tissue of origin of a tumor, but a paper from …
Molecular 
5/5/14 
Molecular Tumor Board Helps in Advanced Cancer Cases
By University of California - San Diego
With accelerating development of personalized cancer treatments matched to a patient's DNA sequencing, proponents say frontline physicians increasingly need help to maneuver through the complex genomic landscape to find …
Test 
5/15/12 
★★★ 
Genetic Test Identifies Eye Cancer Tumors Likely to Spread
By Washington University School of Medicine
Researchers at Washington University School of Medicine in St. Louis have developed a genetic test that can accurately predict whether the most common form of eye cancer will spread …
Cancer 
8/1/11 
Genetic Differences Distinguish Stomach Cancers, Treatment Response
By Duke University Medical Center
SINGAPORE – Stomach cancer is actually two distinct disease variations based on its genetic makeup, and each responds differently to chemotherapy, according to an international team of scientists led …
Cancer 
9/4/12 
Ovarian Cancer Cells Hijack Surrounding Tissues to Enhance Tumor Growth
By Journal of Clinical Investigation
Tumor growth is dependent on interactions between cancer cells and adjacent normal tissue, or stroma. Stromal cells can stimulate the growth of tumor cells; however it is unclear if …
Erlotinib 
4/30/10 
Blood Test May Identify Lung Cancer Patients Likely to Respond to Erlotinib
By European Society for Medical Oncology
Testing for the presence of specific cancer protein 'fingerprints' in the blood of lung cancer patients may be a useful means of identifying a subgroup whose tumors are more …
Cpe-Delta 
2/1/11 
Level of Tumor Protein Indicates Chances Cancer Will Spread
By National Institute of Child Health and Human Development
Researchers at the National Institutes of Health and the University of Hong Kong have discovered that high levels of a particular protein in cancer cells are a reliable indicator …
Topol 
1/4/13 
Scripps Physicians Call for Change in Cancer Tissue Handling
By Scripps Health
SAN DIEGO – Genetic sequencing technology is altering the way cancer is diagnosed and treated, but traditional specimen handling methods threaten to slow that progress. That's the message …
Tumor 
1/16/13 
Body's Ibuprofen, SPARC, Reduces Inflammation And Thus Bladder Cancer Development And Metastasis
By University of Colorado Denver
Cancer researchers are increasingly aware that in addition to genetic mutations in a cancer itself, characteristics of the surrounding tissue can promote or suppress tumor growth. One of these …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese Edition